Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ,improve the screening rate of diabetic retinopathy, and reduce the blindness rate.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

• \- 1: Clear awareness, barrier-free communication

• 2: diabetes

Locations
Other Locations
China
Tianjin Medical University Eye Hospital
RECRUITING
Tianjin
Contact Information
Primary
Juping Liu, Director
tydljp@126.com
13752033227
Time Frame
Start Date: 2024-03-28
Estimated Completion Date: 2025-03-28
Participants
Target number of participants: 18000
Treatments
Diabetic retinopathy screening group
Diabetes patients in the community to accept unified eye test, confirm whether patients with diabetic retinopathy
Related Therapeutic Areas
Sponsors
Leads: Li Xiaorong
Collaborators: Tianjin Medical University Eye Hospital

This content was sourced from clinicaltrials.gov